PolyActiva Pty Ltd: Clinical Trials

7 trials sponsored by PolyActiva Pty Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 active not recruiting, 1 withdrawn. 6 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 4, Active not recruiting 1, Withdrawn 1
Phase 21Active not recruiting 1

Follow PolyActiva Pty Ltd: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluate Efficacy, Safety, Tolerability and Biodegradation of PA5346 Ocular Implant in Patients With Open-Angle Glaucoma or Ocular Hypertension
PA5436 Ocular Implant, 115mcg - Open Angle Glaucoma (OAG), Ocular Hypertension (OH)
Phase 1Active not recruitingPolyActiva Pty Ltd122025-06-102026-07-07
Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension
PA5108 Ocular Implant low dose, PA5108 Ocular Implant, high dose, Latanoprost 0.005% Ophthalmic Solution - Glaucoma, Open-Angle, Ocular Hypertension
Phase 2Active not recruitingPolyActiva Pty Ltd752025-05-312026-07-08
A Study of Levofloxacin Ocular Implant in Patients Undergoing Routine Bilateral Cataract Surgery
Levofloxacin Ocular Implant, Control - Cataract
Phase 1WithdrawnPolyActiva Pty Ltd2023-06-232024-04-12
Study of a Latanoprost Ocular Implant for Treatment of Open Angle Glaucoma or Ocular Hypertension.
100ng/day PA5346 Latanoprost FA SR Ocular Implant - Open Angle Glaucoma, Ocular Hypertension
Phase 1CompletedPolyActiva Pty Ltd12022-03-042024-04-12
Levofloxacin Ocular Implant for Ocular Surgery
Levofloxacin Ocular Implant - Cataract
Phase 1CompletedPolyActiva Pty Ltd52021-01-042021-12-08
Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucoma
PA5108 Latanoprost FA SR Ocular Implant - Open Angle Glaucoma
Phase 1CompletedPolyActiva Pty Ltd372020-03-112025-11-20
Safety and Tolerability of a Prostaglandin Ocular Implant for Treatment of Open Angle Glaucoma
PA5108 - Open-angle Glaucoma
Phase 1CompletedPolyActiva Pty Ltd82018-07-242020-09-16

Conditions studied

Glaucoma, Open-Angle (5)  ·  Ocular Hypertension (3)  ·  Cataract (2)

Interventions

Latanoprost (1)  ·  Ophthalmic Solutions (1)

Countries

Australia (5)  ·  United States (3)  ·  New Zealand (2)

Top investigators

Joseph Gira, MD (1)  ·  Michael Coote (1)  ·  Michael Coote, MD (1)  ·  Nathan Kerr (1)  ·  Tony Wells, MD (1)